Hepatitis C virus non-structural NS3/4A fusion gene
US7226912B2 · kind B2 · utility
6Cited by
85References
84Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 26, 2006 |
| Grant date | Jun 5, 2007 |
| Priority date | — |
| Expiry date | Apr 26, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is the discovery of a novel hepatitis C virus (HCV) isolated from a human patient. Embodiments of the invention include HCV peptides, nucleic acids encoding said HCV peptides, antibodies directed to said peptides, compositions containing said nucleic acids and peptides, as well as, methods of making and using the aforementioned compositions including, but not limited to, diagnostics and medicaments for the treatment and prevention of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.